Synthesis, DFT Characterization and In Silico Evaluation of 1-(4-Methylpiperazin-1-yl-methyl)-3-benzyl-4-(4-hydroxybenzylideneamino)-4,5-dihydro-1H-1,2,4-triazol-5-one (MBHT)
Abstract
In this study, the compound 1-(4-methylpiperazin-1-yl-methyl)-3-benzyl-4-(4-hydroxybenzylideneamino)-4,5-dihydro-1H-1,2,4-triazol-5-one (MBHT), synthesized using the Mannich reaction, was comprehensively investigated using theoretical methods. The stable geometry of the molecule was optimized using the B3LYP and B3PW91 functionals within the framework of density functional theory (DFT) and with the basis set 6-311G(d,p). Structural characterization was performed by determining the functional groups using FT-IR spectroscopy and by detailed investigation of the proton and carbon environments using 1H-NMR and 13C-NMR spectroscopies. Theoretical IR and NMR data were calculated using Gaussian 09W software and the GIAO method; the obtained results were validated by comparing them with experimental findings. The molecule's electronic structure was evaluated in detail through parameters such as HOMO–LUMO energy levels and energy gap, Natural Bond Orbital (NBO) analysis, nonlinear optical (NLO) properties, molecular electrostatic potential (MEP) maps, and Mulliken charge distributions. These analyses provided information about MBHT's electron distribution, reactivity profile, and potential interaction sites. Furthermore, molecular docking studies were performed using PDB:5HS1 and PDB:5EQB proteins to investigate its in-silico potential for biological interaction with candidiasis. In the final part of the study, ADMET (absorption, distribution, metabolism, excretion, and toxicity) analysis was conducted to evaluate MBHT as a drug candidate. The findings reveal both the structural and electronic properties of MBHT, as well as its potential for interaction with biological targets, providing important information regarding the compound's suitability for the drug development process.
Keywords
References
- Beytur M, and Yüksek H. Yeni 3-(3-Klorobenzil)-4-(3-Sinnamoiloksibenzilidenamino)-4,5-Dihidro-1H-1,2,4-Triazol-5-On Bileşiğinin Gaussian Programi Kullanilarak Spektroskopik Özelliklerinin İncelenmesi. Caucasian J. Sci 2014; 1(1):149–166.
- Medetalibeyoğlu H, and Yüksek H. 3-Metil-4-[4-(dimetilamino)-benzilidenamino]-4,5-dihidro-1H-1,2,4-triazol-5-on’un Bazı Deneysel Ölçümleri ve Teorik Çalışmaları. Afyon Kocatepe Üniversitesi Fen Ve Mühendislik Bilimleri Dergisi 2019; 19(3):556–570.
- El-Sebaey SA. Recent Advances in 1,2,4-Triazole Scaffolds as Antiviral Agents. ChemistrySelect 2020; 5(37):11654–11680.
- Koparir P, Parlak AE, Karatepe A, and Omar RA. Elucidation of potential anticancer, antioxidant and antimicrobial properties of some new triazole compounds bearing pyridine-4-yl moiety and cyclobutane ring. Arabian J. Chem 2022; 15(7):103957.
- Meylani V, Rizal Putra R, Miftahussurur M, Sukardiman S, Eko Hermanto F, and Abdullah A. Molecular docking analysis of Cinnamomum zeylanicum phytochemicals against Secreted Aspartyl Proteinase 4–6 of Candida albicans as anti-candidiasis oral. Results Chem 2023; 5: 100721.
- Verma R, Pradhan D, Nayek A, Singh H, Jain AK, and Khan LA. Target-based drug repurposing against Candida albicans—A computational modeling, docking, and molecular dynamic simulations study. J. Cell. Biochem 2022; 123(2):289–305.
- Boy S et al. Synthesis, Spectroscopic Analysis, and in Vitro/in Silico Biological Studies of Novel Piperidine Derivatives Heterocyclic Schiff-Mannich Base Compounds. Chem. Biodivers. 2021; 18(12):e2100433.
- Boy S, Kotan G, Beytur M, and Yuksek H. Quantum Chemical Calculations of 3-Benzyl-4-(3-Ethoxy-2-(4-Toluenesulfonlyoxy)-Benzlyideneamino]-4,5-Dihydro-1H-1,2,4-Triazol-5-One. Eur. Proc. Sci. Technol. Eng. Math 2022; 20:10–20.
Details
Primary Language
English
Subjects
Organic Chemistry (Other)
Journal Section
Research Article
Authors
Songül Boy
0000-0002-6508-8600
Türkiye
Kenan Gören
0000-0001-5068-1762
Türkiye
Mehmet Bağlan
*
0000-0002-7089-7111
Türkiye
Sevda Manap
0000-0002-5025-9622
Türkiye
Haydar Yüksek
0000-0003-1289-1800
Türkiye
Publication Date
September 30, 2026
Submission Date
March 28, 2026
Acceptance Date
July 12, 2026
Published in Issue
Year 2026 Volume: 21 Number: 2